EXAM 5 systemic antifungals Flashcards

1
Q

candidemia risk factors

A

broad spectrum ABX

central venous (CVC, PICC)

Receipt of parenteral nutrition (TPN)

Neutropenia (ANC<500 cells/mm)

Receipt of immunosuppressive agents

Surgery

Intraabdominal perforation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Candidemia treatment

A

start first: echinocandin - micafungin

fluconazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

candidemia treatment duration

A

treat for 14 days after first negative blood culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

candidemia treatment - neutropenic

A

Initial therapy: echinocandin

lipid formulation of amphotericin b

either 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

candidemia preferred treatment

A

fluconazole: albicans, parapsilosis, tropicalis, lusitaniae

Voriconazole: krusei

echinocandins: glabrata, krusei, lusitaniae, auris

amphotericin: parapsilosis, krusei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

histoplasmosis clinical presentation

A

disseminated histoplasmosis: multiple organs

heptaosplenomegaly, chest pain

CNS histoplasmosis symptoms: fever, headache, seizure, mental status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

histoplasmosis treatment - immunocompetent host

A

asymptomatic - no therapy

mild-moderate - intraconazole is DOC for 6-12 weeks

moderate-severe - amphotericin 1-2 weeks then itraconazole for 12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

histoplasmosis treatment - immunocompromised host

A

therapy required for all patients

moderate-severe - amphotericin 1-2 weeks then itraconazole for 12 weeks

less severe disease: itraconazole for 12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

coccidioidomycosis treatment

A

most patients with primary pulmonary disease recover without therapy

Primary respiratory infection: fluconazole 3-6 months

Symptomatic chronic cavitary pneumonia: fluconazole 12 month

diffuse pneumonia w/o bilateral or miliary infiltrates: amphotericin B, followed by azole - 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

cryptococcosis facts

A

causitive pathogen: neoformans

cell-mediated immunity plays a major role in host defense against infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cryptococcosis clinical presentation

A

pulmonary: cough, rales, SOB

meningitis: mental status change, nuchal rigidity, fever, headache
patients with HIV tend to have less symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

cryptococcosis diagnosis

A

meningitis (most common presentation) - perform lumbar puncture and look at fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cryptococcal meningitis treatment - non HIV pts

A

induction: Amphotericin B + flucytosine for at least 4 weeks

consolidation: fluconazole 400-800 QD for 8 weeks

maintenance: fluconazole 200-400 QD for 6-12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

cryptococcal meningitis treatment - HIV pts

A

induction: Amphotericin B + flucytosine for >2 weeks

consolidation: fluconazole 400-800 QD for 8 weeks

maintenance: fluconazole 200-400 QD for 6-12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

invasive pulmonary aspergillosis treatment

A

voriconazole
continue therapy for 6-12 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

aspergillosis prophylaxis

A

used for immunocompromised pts

Posaconazole